The company is committed to serving the pharmaceutical, pesticide, biological and material fields, the main business includes: new drug research and development outsourcing services, pharmaceutical, pesticide, biological and material intermediates customized research and development and production, generic drugs and bulk fine product process development and optimization. The company has developed and accumulated a large number of technologies for industrializing products in the subsectors of pharmaceutical intermediates, apis, apis, OLED material intermediates, amino acids and Linker, and the products have excellent quality.
In process development, the company is committed to combining chemical and chemical technology to develop green, safe and continuous process processes and methods to meet the regulatory requirements for chemical production processes. The team has rich theoretical and first-hand experience in the synthesis route selection, process optimization, technology selection, equipment selection and actual production of bulk chemicals (100 tons)